| # | Ticker | Company | Price | Chg % | Mkt Cap | P/E | EPS Growth TTM | Div Yield | Sector | Return 1Y | Revenue Growth… | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals Incorporated | $522.25 | -1.4% | $132.84B | 34.1 | 530.1% | — | Healthcare | 13.7% | 10.4% | ||
| 2 | Regeneron Pharmaceuticals, Inc. | $676.23 | 4.1% | $70.26B | 16.3 | 4.5% | 0.5% | Healthcare | 25.7% | 5.9% | ||
| 3 | argenx SE | $919.94 | 0.3% | $56.93B | 46.9 | 279.7% | — | Healthcare | 68.5% | 174% | ||
| 4 | Alnylam Pharmaceuticals, Inc. | $321.59 | 2.7% | $42.91B | 138.0 | 301.4% | — | Healthcare | -0.8% | 82.6% | ||
| 5 | Revolution Medicines, Inc. | $190.46 | 0.2% | $40.49B | -32.0 | -77.3% | — | Healthcare | 419.4% | — | ||
| 6 | Moderna, Inc. | $79.77 | -2.5% | $31.64B | -11.0 | 6.6% | — | Healthcare | 166.8% | -29.1% | ||
| 7 | Spyre Therapeutics, Inc. | $88.89 | 0.1% | $30.76B | -44.9 | 12.4% | — | Healthcare | 481% | — | ||
| 8 | Roivant Sciences Ltd. | $36.31 | 2.6% | $26.12B | -84.4 | 25% | — | Healthcare | 238.1% | -67.7% | ||
| 9 | Royalty Pharma plc | $57.80 | 1.5% | $24.76B | 32.1 | -23.7% | 1.2% | Healthcare | 62.4% | 7.8% | ||
| 10 | United Therapeutics Corporation | $563.70 | 3% | $23.93B | 20.2 | 7.9% | — | Healthcare | 94.1% | 5.9% | ||
| 11 | BioNTech SE | $94.29 | 0.4% | $23.84B | -18.3 | -56.1% | — | Healthcare | -14.3% | 1.9% | ||
| 12 | Incyte Corporation | $118.05 | 2.1% | $23.58B | 18.4 | 2112.5% | — | Healthcare | 75.5% | 21.5% | ||
| 13 | Genmab A/S | $29.18 | 4.2% | $17.91B | 18.9 | -59.7% | — | Healthcare | 42.2% | -34.4% | ||
| 14 | Ascendis Pharma A/S | $266.97 | -0.4% | $16.49B | -64.5 | 229.7% | — | Healthcare | 51.7% | 135.3% | ||
| 15 | Jazz Pharmaceuticals plc | $247.72 | 1.5% | $15.54B | -42.4 | -98.5% | — | Healthcare | 130.2% | 9.2% | ||
| 16 | BridgeBio Pharma, Inc. | $77.91 | 0.2% | $15.26B | -20.6 | -6.2% | — | Healthcare | 79.1% | 355.2% | ||
| 17 | Exelixis, Inc. | $57.08 | 2.8% | $14.5B | 20.5 | 37.9% | — | Healthcare | 29.3% | 3.3% | ||
| 18 | Ionis Pharmaceuticals, Inc. | $86.33 | 3.8% | $14.27B | -36.3 | 30.1% | — | Healthcare | 106.6% | 47.5% | ||
| 19 | Axsome Therapeutics, Inc. | $249.76 | 3% | $12.85B | -67.9 | 35.4% | — | Healthcare | 132.3% | 63.9% | ||
| 20 | Madrigal Pharmaceuticals, Inc. | $545.36 | 3% | $12.57B | -42.4 | 29.1% | — | Healthcare | 88.6% | 256.8% | ||
| 21 | Summit Therapeutics Inc. | $15.88 | -0.3% | $12.31B | -11.0 | -414.1% | — | Healthcare | -29.8% | — | ||
| 22 | Arrowhead Pharmaceuticals, Inc. | $86.97 | 0.5% | $12.25B | -7128.7 | -50.7% | — | Healthcare | 416.4% | 14.1% | ||
| 23 | BioMarin Pharmaceutical Inc. | $60.35 | 2.7% | $11.61B | 33.5 | -48.3% | — | Healthcare | 5.1% | 9.9% | ||
| 24 | Bio-Techne Corporation | $71.00 | 0.5% | $11.12B | 154.3 | -15.9% | 0.4% | Healthcare | 37.8% | 0.2% | ||
| 25 | Krystal Biotech, Inc. | $368.60 | -1.6% | $10.87B | 53.9 | 79.8% | — | Healthcare | 163.8% | 25.1% | ||
| 26 | Cytokinetics, Incorporated | $85.56 | -0% | $10.54B | -13.1 | -29.1% | — | Healthcare | 156.5% | 450.6% | ||
| 27 | Corcept Therapeutics Incorporated | $94.04 | 2.7% | $10.1B | 114.7 | -69.8% | — | Healthcare | 39.2% | 12.2% | ||
| 28 | Kymera Therapeutics, Inc. | $119.24 | 3.9% | $9.74B | -32.3 | -15.5% | — | Healthcare | 172.2% | -12.6% | ||
| 29 | Halozyme Therapeutics, Inc. | $81.57 | 1% | $9.68B | 31.9 | -26.1% | — | Healthcare | 50.4% | 39.1% | ||
| 30 | Praxis Precision Medicines, Inc. | $323.95 | 3.3% | $9.36B | -24.0 | -24.7% | — | Healthcare | 594% | -100% | ||
| 31 | Abivax S.A. | $142.17 | -1.3% | $9.32B | -26.8 | 16.6% | — | Healthcare | 1688.3% | -100% | ||
| 32 | Alkermes plc | $55.22 | 0.1% | $9.2B | 38.6 | -56.9% | — | Healthcare | 88.9% | 3.2% | ||
| 33 | ImmunityBio, Inc. | $8.76 | -1.7% | $9.17B | -23.1 | -52.4% | — | Healthcare | 222.1% | 351.5% | ||
| 34 | Nuvalent, Inc. | $123.77 | 0% | $9.1B | -21.2 | -38% | — | Healthcare | 58.8% | — | ||
| 35 | Protagonist Therapeutics, Inc. | $140.85 | 7.1% | $9.06B | -68.7 | -341.3% | — | Healthcare | 182.4% | -91.5% | ||
| 36 | Crinetics Pharmaceuticals, Inc. | $83.53 | 98.7% | $8.81B | -16.9 | -34.6% | — | Healthcare | 187.4% | 2277.5% | ||
| 37 | Vaxcyte, Inc. | $60.67 | 6.5% | $8.76B | -10.8 | -68.5% | — | Healthcare | 89.6% | — | ||
| 38 | Apogee Therapeutics, Inc. | $133.54 | 0% | $8.26B | -31.6 | -19.3% | — | Healthcare | 240.3% | — | ||
| 39 | Immunovant, Inc. | $40.09 | 3.9% | $8.23B | -14.5 | -1.5% | — | Healthcare | 144.2% | — | ||
| 40 | TG Therapeutics, Inc. | $53.52 | -2.6% | $8.19B | 19.3 | 1070.7% | — | Healthcare | 48.7% | 81.3% | ||